IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2004;45:4368-4377.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-0413

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weinreb, R. N.
Right arrow Articles by Strongin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weinreb, R. N.
Right arrow Articles by Strongin, A.

Prostaglandin FP Agonists Alter Metalloproteinase Gene Expression in Sclera

Robert N. Weinreb,1 James D. Lindsey,1 George Marchenko,2 Natalia Marchenko,2 Mila Angert,1 and Alex Strongin2

1From the Hamilton Glaucoma Center and Department of Ophthalmology, University of California San Diego, La Jolla, California; and the 2Burnham Institute, La Jolla, California.

PURPOSE. The present study was undertaken to determine whether exposure of the sclera to prostaglandin (PG)F2{alpha} or to the PGF2{alpha} analogue latanoprost acid alters mRNA for matrix metalloproteinases.

METHOD. Fifteen human eye bank eyes were studied. Circular pieces of sclera were either immediately preserved in a stabilization reagent or cultured in low-serum DMEM/F-12 medium. The cultures were treated for 24 hours with medium supplemented with PGF2a, latanoprost acid, or vehicle. Total RNA was then isolated, and the expression of mRNA for matrix metalloproteinase (MMP)-1, -2, -3, -8, -9, -10, and -12 were determined by real-time PCR. All results were normalized according to the GAPDH mRNA in each sample. Altered mRNA expression after PG treatments also was evaluated with microarrays containing 19 MMP genes and 4 tissue inhibitor of matrix metalloproteinase (TIMP) genes.

RESULTS. Real-time PCR results showed that 24 hours of exposure to 100 nM PGF2{alpha} significantly increased mRNA for MMP-1 and -9 (P < 0.06 Wilcoxon test) and that exposure to 100 nM latanoprost acid significantly increased mRNA for MMP-9 (P < 0.06 Wilcoxon test). Array analysis demonstrated increases of MMP-3 and -10 mRNA after exposure to 100 nM latanoprost and further increases after exposure to 200 nM latanoprost. The array results also showed that latanoprost induced dose-dependent increases in the expression of TIMP-1, -2, and -3 mRNA in the scleral cultures.

CONCLUSIONS. PGF2{alpha} and latanoprost acid induce coordinated alterations of MMP gene transcription in scleral organ cultures. These results indicate that PGs can directly trigger MMP gene transcription changes within the sclera. These changes support a role for increased MMPs in the enhancement of uveoscleral outflow that occurs after topical treatment with latanoprost.





This article has been cited by other articles:


Home page
IOVSHome page
J. D. Lindsey, J. G. Crowston, A. Tran, C. Morris, and R. N. Weinreb
Direct Matrix Metalloproteinase Enhancement of Transscleral Permeability
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 752 - 755.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. Gutierrez-Ortiz, M. A. Teus, and G. Bolivar
Short-Term Effects of Latanoprost on Anterior Chamber Depth in Patients with Glaucoma or Ocular Hypertension
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4856 - 4859.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D.-J. Oh, J. L. Martin, A. J. Williams, P. Russell, D. E. Birk, and D. J. Rhee
Effect of latanoprost on the expression of matrix metalloproteinases and their tissue inhibitors in human trabecular meshwork cells.
Invest. Ophthalmol. Vis. Sci., September 1, 2006; 47(9): 3887 - 3895.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D.-J. Oh, J. L. Martin, A. J. Williams, R. E. Peck, C. Pokorny, P. Russell, D. E. Birk, and D. J. Rhee
Analysis of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human ciliary body after latanoprost.
Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 953 - 963.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
Q. Li, F. Jimenez-Krassel, Y. Kobayashi, J. J Ireland, and G. W Smith
Effect of intrafollicular indomethacin injection on gonadotropin surge-induced expression of select extracellular matrix degrading enzymes and their inhibitors in bovine preovulatory follicles.
Reproduction, March 1, 2006; 131(3): 533 - 543.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology